Results 161 to 170 of about 16,625 (226)

Artemisinin-Quinidine Combination for Suppressing Ventricular Tachyarrhythmia in an Ex Vivo Model of Brugada Syndrome. [PDF]

J Korean Med Sci
Jeong HK, Yoon N, Kim YR, Lee KH, Park HW.   +4 more
europepmc   +1 more source

Resolution of severe dilated cardiomyopathy with significant arrhythmia burden using hydroquinidine, in addition to guideline-directed medical therapy, in a patient with a pathogenic <i>SCN5A</i> variant: a case report. [PDF]

Eur Heart J Case Rep
Griffiths RLM, Cowburn PJ, Mercer C, Papadakis M, Behr ER.   +4 more
europepmc   +1 more source

Two-pore domain potassium channel TREK-1 contributes to arachidonic acid-induced Ca²⁺ signaling in human fibroblast-like synovial cells. [PDF]

Biochem Biophys Rep
Khaltar B, Toyoda F, Kumagai K, Yayama T, Tsedenbal B, Umeda K, Saito H, Lkhagvasuren N, Kubo M, Imai S.   +9 more
europepmc   +1 more source

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. [PDF]

Europace
Merino JL, Tamargo J, Blomström-Lundqvist C, Boriani G, Crijns HJGM, Dobrev D, Goette A, Hohnloser SH, Naccarelli GV, Reiffel JA, Tfelt-Hansen J, Martínez-Cossiani M, Camm AJ, Almendral Garrote JM, Średniawa B, Kułakowski P, Savelieva I, Potpara T, Gorenek B, Zamorano JL.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Quinidine Revisited

American Journal of Medicine, 2009
One of the earliest antiarrhythmic drugs developed, quinidine had a significant role in the treatment of many arrhythmias. After concerns for increased risk of ventricular arrhythmia and death with quinidine emerged, the use of quinidine fell dramatically in favor of newer antiarrhythmic medications.
Paul Schweitzer
exaly   +3 more sources